Key factor behind aggressive prostate cancer identified in new study

Researchers at the Fred Hutch Cancer Center have identified a key factor behind aggressive prostate cancer that could help determine whether the disease will respond to treatment or become more severe.

According to Russia Today, the study found that a single transfer RNA (tRNA) molecule may play a significant role in defining prostate cancer cell identity and influencing their response to therapy.

The researchers focused on understanding the mechanisms driving this transformation, examining the role of these molecules involved in protein synthesis within cells. They discovered that introducing this molecule to treatment-resistant tumors could restore their sensitivity to therapies targeting the androgen receptor.

The team is also investigating whether these molecules could serve as biomarkers to identify tumors most likely to resist treatment, or as targets for developing new therapies for aggressive prostate cancer.